Select a community
All Communities
Home > Community Treatment Reports > Diclofenac Epolamine Patch Treatment Report
What is Diclofenac Epolamine Patch?

A prescription topical treatment for acute (short-term) pain due to minor strains, sprains, and contusions (bruises). The patch releases a drug called diclofenac epolamine is effective in the treatment of acute migraine attacks. It is sold under a brand name Flector Patch.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
fibromyalgia flares 1 0
pain, ankle 1 0
Pain, arm 1 0
Joint pain, stiffness 1 0
osteoarthritis 1 0
Pain 1 0

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
0 0%
Mild
1 50%
None
1 50%

Most commonly reported side effects

Lightheadedness
1 50%
burning skin
1 50%
  • Mild
  • Moderate
  • Severe

Dosages

  12hours as needed 1mg as needed 1other as needed 1 other daily 1.3 other daily
  1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Diclofenac Epolamine Patch (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work
1 50% Did not seem to work: 50%
Other
1 50% Other: 50%

See all 2 patients who’ve stopped taking Diclofenac Epolamine Patch

Currently Taking Diclofenac Epolamine Patch

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
3
2
0
1

Stopped Taking Diclofenac Epolamine Patch

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
1
0
0
1
0

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
1 50%
Usually
1 50%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
2 100%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
1 50%
< $25
1 50%

Report created on November 21, 2009.